期刊文献+

盐酸右美托咪定在危重症患者机械通气的临床研究 被引量:9

Clinical study of dexmedetomidine hydrochloride in mechanical ventilation for critical patients
下载PDF
导出
摘要 目的探讨盐酸右美托咪定对危重症患者机械通气的临床效果。方法选择我院于2012年1月~2013年7月人住重症监护病房(ICU)的需要机械通气的120例危重症患者,将其随机地分为治疗组和对照组,治疗组60例,给予盐酸右美托咪定镇静治疗;对照组60例,给予咪达唑仑镇静治疗。记录两组患者镇静中各时点的呼吸、循环、镇静指标及机械通气总时间、入住ICU时间,进行对比分析。结果治疗组的呼吸、循环等指标均好于对照组,同时治疗组患者的Ramsay评分、机械通气总时间、入住ICU时间均明显少于对照组,且两组间的差异具有统计学意义(P〈0.01)。结论盐酸右美托咪定治疗相比咪达唑仑治疗的镇静效果更好,安全性高,具有重要的临床应用价值。 Objective To investigate clinical effect of dexmedetomidine hydrochloride in mechanical ventilation for critical patients. Methods 120 cases of critical patients requiring mechanical ventilation in our ICU from January 2012 to July 2013 were divided into the treatment group(60),treated by dexmedetomidine hydrochloride and the control group (60),treated by midazolam.The breathing,circulation,calm indicators,total time of mechanical ventilation,ICU stay of two groups were analyzed. Results After treatment,the respiratory, circulatory and other indicators of the treatment group were better than that of the control group,while the Ramsay score,the total duration of mechanical ventilation and ICU stay of the treatment group were significantly less than that of the control group,with the significant difference (P 〈 0.01 ). Conclusion Compared to midazolam sedation treatment,dexmedetomidine hydrochloride in treatment for critical patients has better,safe,important clinical value.
出处 《中国医药科学》 2014年第12期82-83,111,共3页 China Medicine And Pharmacy
关键词 危重症患者 机械通气 盐酸右美托咪定 临床效果 Critical patients Mechanical ventilation Dexmedetomidine hydrochloride Clinical effect
  • 相关文献

参考文献10

二级参考文献177

  • 1安友仲,邱海波,黄青青,康焰,管向东.中国重症加强治疗病房患者镇痛和镇静治疗指导意见(2006)[J].中华外科杂志,2006,44(17):1158-1166. 被引量:243
  • 2重症加强治疗病房病人镇痛和镇静治疗指南(2006)[J].中国实用外科杂志,2006,26(12):893-901. 被引量:215
  • 3BHANA N,GOA K L,MCCLELLAN K J.Dexmedetomidine[J].Drugs,2000,59:263-268. 被引量:1
  • 4ANTTILA M,PENTTILA J,HELMINEN A,et al.Bioavailability of dexmedetomidine after extravascular doses in healthy subjects[J].Br J Clin pharmacol,2003,56(6):691-693. 被引量:1
  • 5MAZE M,SCARFINI C,CAVALIERE F.New agents for sedation in the intensive care unit[J].Crit Care Clin,2001,17:881-897. 被引量:1
  • 6NELSON L E,LU J,GUO T Z,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003,98:428-436. 被引量:1
  • 7COULL J T,JONESM,EGAN T,et al.Attentional effects of noradrenaline vary with arousal level:selective activation of thalamic pulvinar in humans[J].Neuro Image,2004,22:315-322. 被引量:1
  • 8SALLINEN J,HAAPALINNA A,VIITAMAA T,et al.Adrenergica2C-receptors modulate the acoustic startle reflex,prepulse inhibition,and aggressionin mice[J].Neurosci,1998,18:3035-3042. 被引量:1
  • 9EISENACH J C.[Alpha]2 agonists and analgesia[J].Exp Opin InvestD rugs,1994,3:1005-1010. 被引量:1
  • 10SHEHABI Y,RUETTIMANN U,ADAMSON H,et al.Dexmedetomidine infusion for morethan 24 hours in critically ill patients:sedative and cardiovascular effects[J].Intensive caro medicine,2004,30(12):2188-2196. 被引量:1

共引文献524

同被引文献66

  • 1王先圆.右美托咪定联合舒芬太尼在AECOPD机械通气患者镇痛镇静的效果影响[J].中西医结合心血管病电子杂志,2020,0(2):29-29. 被引量:2
  • 2ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:Appendix(附录)ⅪJ. 被引量:4
  • 3ZHANG YZ(张英卓).Clinical Observation of Dexmedetomidine Hydrochloride on Sedation and Analgesia of ICU Patients(右美托咪定用于重症监护患者镇静镇痛的临床观察)[D].Changchun(长春):Jilin University(吉林大学),2013. 被引量:1
  • 4MURDOCH S,COHEN A.Intensive care sedation:a review of current British practice[J].Intensive Care Med,2000,26(7):922. 被引量:1
  • 5ESMAOGLU A,ULGEY A,AKIN A,et al.Comparison between dexmedetomidine and midazolam for sedation of eclampsia patients in the intensive care unit[J].J Crit Care,2009,24(4):551. 被引量:1
  • 6PASIN L,LANDONI G,NARDELLI P,et al.Dexmedetomidine reduces the risk of delirium,agitation and confusion in critically ill patients:A meta-analysis of randomized controlled trials[J].J Cardiothorac Vascul Anestha,,2014,28(6):1459. 被引量:1
  • 7JIANG RL(姜瑞玲).Studies on Quality of Dexmedetomidine Hydrochloride(盐酸右美托咪定的质量研究)[D].Jinan(济南):Shangdong University(山东大学),2012. 被引量:1
  • 8ZHOU HJ(Chief Translator)(周海钧主译).International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use(药品注册的国际技术要求).Quality Topics(质量部分)[M].Beijing(北京):People's Medical Publishing House(人民卫生出版社),2000. 被引量:1
  • 9盛照志,李清涛,孙峰京.盐酸右美托咪定注射液的稳定性研究[J].齐鲁药事,2010,29(2):106-107. 被引量:5
  • 10余振喜,庾莉菊,黄海伟,张启明.浅谈HPLC法测定有关物质时已知杂质的计算方法[J].中国药品标准,2010,11(4):278-282. 被引量:36

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部